John G Gribben Selected Research

John G Gribben Research Topics

Disease

59	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2002
51	Neoplasms (Cancer) 11/2022 - 01/2002
29	Lymphoma (Lymphomas) 07/2023 - 03/2002
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 11/2006
17	Leukemia 01/2022 - 10/2004
10	Disease Progression 01/2022 - 08/2004
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 01/2002
9	Residual Neoplasm 01/2022 - 12/2003
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2012
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 07/2013
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2006
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 04/2012
4	Hematologic Neoplasms (Hematological Malignancy) 10/2016 - 03/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 12/2003
3	Multiple Myeloma 01/2022 - 06/2002
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 03/2002
2	Virus Diseases (Viral Diseases) 05/2023 - 01/2018
2	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2005
2	Infections 10/2019 - 11/2018
2	Neutropenia 10/2019 - 11/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 07/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2006 - 01/2002
1	Thrombocytopenia (Thrombopenia) 05/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Tumor Lysis Syndrome 01/2020
1	Leukopenia 10/2019
1	Neuroendocrine Carcinoma 01/2019
1	Sudden Death 01/2019
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

16	Rituximab (Mabthera)FDA Link 07/2023 - 03/2002
10	obinutuzumabIBA 07/2023 - 08/2016
10	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 07/2002
10	AntigensIBA 01/2017 - 09/2002
10	Immunoglobulins (Immunoglobulin)IBA 04/2009 - 03/2002
9	Lenalidomide (CC 5013)FDA Link 10/2019 - 09/2009
9	fludarabineIBA 11/2018 - 02/2004
8	Biomarkers (Surrogate Marker)IBA 06/2023 - 03/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 03/2002
7	ibrutinibIBA 01/2022 - 01/2018
6	Chlorambucil (Leukeran)FDA Link 01/2022 - 04/2014
5	LigandsIBA 10/2016 - 08/2012
4	Chimeric Antigen ReceptorsIBA 01/2024 - 12/2013
4	Phosphotransferases (Kinase)IBA 01/2022 - 02/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2005
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 03/2002
4	Monoclonal AntibodiesIBA 03/2009 - 01/2002
3	venetoclaxIBA 01/2020 - 01/2019
3	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2014
3	Bendamustine Hydrochloride FDA Link 01/2018 - 08/2016
3	Isoantigens (Alloantigen)IBA 01/2016 - 09/2008
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 03/2002
3	Vincristine (Oncovin)FDA LinkGeneric 09/2015 - 03/2002
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 01/2003
3	AntibodiesIBA 05/2013 - 08/2008
3	Alemtuzumab (Campath)FDA Link 01/2011 - 07/2006
2	axicabtagene ciloleucelIBA 01/2024 - 01/2022
2	NucleotidesIBA 01/2022 - 07/2014
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022 - 02/2014
2	EnzymesIBA 01/2022 - 06/2015
2	Immunoglobulin Variable RegionIBA 12/2020 - 03/2007
2	AnthracyclinesIBA 10/2020 - 04/2012
2	CytokinesIBA 01/2018 - 01/2003
2	Bortezomib (Velcade)FDA Link 01/2012 - 11/2008
2	Actins (F Actin)IBA 09/2010 - 11/2009
1	GalliumIBA 07/2023
1	Thrombopoietin (c-mpl Ligand)IBA 05/2023
1	Ferritins (Ferritin)IBA 05/2023
1	Circulating Tumor DNAIBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2021
1	Gemcitabine FDA Link 01/2021
1	ChemokinesIBA 01/2021
1	Estrogen ReceptorsIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 10/2020
1	Tamoxifen FDA LinkGeneric 10/2020
1	CateninsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	ethyl pyruvateIBA 01/2019
1	ofatumumab FDA Link 11/2018

Therapy/Procedure

44	Therapeutics 01/2024 - 01/2002
20	Stem Cell Transplantation 01/2018 - 01/2002
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
11	Immunotherapy 01/2021 - 06/2002
10	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2003
8	Transplantation 01/2018 - 01/2002
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2008 - 01/2003
3	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 11/2012
2	Salvage Therapy 12/2023 - 06/2007
1	Precision Medicine 11/2022
1	Adjuvant Radiotherapy 10/2020
1	Neoadjuvant Therapy 10/2020